HOME >> BIOLOGY >> NEWS
Terra spacecraft and ER-2 aircraft begin study of Southern Africa's environment

Pietersburg, South Africa -- NASA's Terra spacecraft and ER-2 high-altitude aircraft made their first synchronized scientific observations over Southern Africa today as part of the six-week Southern African Regional Science Initiative (SAFARI 2000) to study the region's ecosystems, air quality and land use.

The target on this first "stacked" flight was the haze in the atmosphere, specifically the gas carbon monoxide, which is a major component of air pollution. During the current dry season in Southern African, thick haze is produced by the burning of vegetation and industrial pollution sources. This haze can last for weeks over the region.

"I am quite pleased with the first coordinated flight of the ER-2 and Terra today," said Michael D. King of NASA's Goddard Space Flight Center, and SAFARI 2000 mission scientist for the ER-2. "We concentrated on comparing measurements of carbon monoxide and methane by Terra's MOPITT (Measurements of Pollution in the Troposphere) instrument and the ER-2's MOPITT-A instrument."

In addition, air samples along the spacecraft's track were collected by the South African Weather Bureau Aerocommander 690A aircraft. The South African plane, one of two participating in SAFARI 2000, made intricate spiral descents through the atmosphere to sample the haze.

Terra flew over the Indian Ocean along the eastern coast of Southern Africa today at 10:22 a.m. local time. Instruments onboard the ER-2 made measurements of the atmosphere at 60,000 feet along the spacecraft's track within minutes of the overpass. The aircraft then returned inland to sample the hazy air over South Africa.

"We're excited about the opportunity to fly with NASA's ER-2 for the first time in this campaign," said Bob Swap of the University of Virginia, principal investigator of the South African plane that flew today. "We're hoping that the information gathered from this flight will be valuable for the global observations of the atmosphere that MOPI
'"/>

Contact: Allen Kenitzer
allen.kenitzer@gsfc.nasa.gov
301-286-2806
NASA/Goddard Space Flight Center
17-Aug-2000


Page: 1 2

Related biology news :

1. An alternative form of chemotherapy? A means for reusable spacecraft?
2. NCAR aircraft, ground instruments to track carbon dioxide uptake
3. Beetles could prove a hit with the aircraft industry
4. From the bone of a horse, a new idea for aircraft structures
5. New Zealand aircraft to fly mission to USA McMurdo Station
6. Scientists, ships, aircraft to profile Asian pollution and dust
7. New hydrothermal vents discovered as South Pacific Odyssey research begins
8. DCI donor services begins distribution of tissue implants
9. Wilex & Fox Chase Cancer Center begin trial w/ novel compound targeting tumor invasion & metastasis
10. Landmark, pivotal Phase IIb/III trial of biotoxin for cancer pain begins
11. Researchers begin study to protect against anthrax

Post Your Comments:
(Date:8/26/2015)... 26, 2015 The report "Multi-Factor Authentication ... Factor), Application (Travel & Immigration, Government, Banking, Defense, Commercial ... to 2020", published by MarketsandMarkets, Multi-Factor Authentication Market is ... at a CAGR of 17.7% between 2015 and 2020. ... igures spread through 169 P ...
(Date:8/24/2015)... CAPE TOWN, South Africa , August 24, 2015 /PRNewswire/ ... awarded Germany ,s largest biometrics manufacturer DERMALOG ... with the "2015 African Biometrics Company of the ... installation in Nigeria .   ... ) and http://www.presseportal.de/nr/8896 - On Thursday ...
(Date:8/20/2015)... , Aug. 20, 2015 The wearable ... that are active and healthy. However, wearable technology ... hospital environment to help improve diagnostic capabilities and ... from the Wearable Technologies Conference 2015 , ... applications for wearables in healthcare.    ...
Breaking Biology News(10 mins):Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 2Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 3Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 4Multi-Factor Authentication Market Worth 9.60 Billion USD by 2020 5Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 2Frost & Sullivan Honors DERMALOG with Biometrics Prize for Achievements in Africa 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
(Date:8/27/2015)... ... August 27, 2015 , ... Inc. Magazine released its annual ... Solutions as number 1,361 in growth for the three years through 2014. Being named ... fastest-growing privately held organizations in the country. , “We are thrilled to make ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... recently presented new data on the relationship of genetics and hypertension at the ... on Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts an ...
(Date:8/26/2015)... , Aug. 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of foodborne ... present at the Sidoti & Company Emerging Growth Conference ... be held at the New York Marriott Marquis. ... be available through the investor relations section of Roka ...
(Date:8/26/2015)... 26, 2015  Platform therapeutic company Symic Biomedical, ... a $1.5M Phase II SBIR grant from the ... its therapeutic agent to reduce arteriovenous fistula (AVF) ... stage renal disease (ESRD) patients undergoing hemodialysis. The ... Diabetes and Digestive and Kidney Diseases (NIDDK), will ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
Cached News: